LABFF.US Laboratorios Farmaceuticos Rovi S.A

Healthcare Biotechnology USA Stocks
67.17 USD
Close of Nov 15, 2026
67.17 90.61
Market cap
USD 3.44B
P/E
15.9x
P/B
4.40x
ROE
27.2%
Dividend yield
1.63%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is LABFF.US undervalued?

Graham number
Price67.17
Graham value38.09
Premium76.3%

LABFF.US trades 76.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Laboratorios Farmaceuticos Rovi S.A fundamental analysis

No fundamental analysis for Laboratorios Farmaceuticos Rovi S.A yet.

Laboratorios Farmaceuticos Rovi S.A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Laboratorios Farmaceuticos Rovi S.A

Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It also provides hospital products, such as Iomeron and Iopamiro, …

Full company profile